Jonathan E. Lim, President, CEO at HALOZYME THERAPEUTICS INC (HALO), sold 19,100 shares at $10.34 ($198K) on 2007-05-31, disclosed to the SEC on 2007-06-01.
Scheduled sale ($198k) by President, CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.17 | 200 | $2K | 1.0% |
| 2 | $10.21 | 600 | $6K | 3.1% |
| 3 | $10.22 | 100 | $1K | 0.5% |
| 4 | $10.24 | 100 | $1K | 0.5% |
| 5 | $10.25 | 100 | $1K | 0.5% |
| 6 | $10.26 | 1,000 |
| $10K |
| 5.2% |
| 7 | $10.27 | 1,500 | $15K | 7.8% |
| 8 | $10.28 | 1,117 | $11K | 5.8% |
| 9 | $10.29 | 1,400 | $14K | 7.3% |
| 10 | $10.30 | 1,383 | $14K | 7.2% |
| 11 | $10.31 | 100 | $1K | 0.5% |
| 12 | $10.32 | 1,400 | $14K | 7.3% |
| 13 | $10.33 | 700 | $7K | 3.7% |
| 14 | $10.34 | 200 | $2K | 1.0% |
| 15 | $10.35 | 400 | $4K | 2.1% |
| 16 | $10.37 | 600 | $6K | 3.1% |
| 17 | $10.38 | 500 | $5K | 2.6% |
| 18 | $10.39 | 1,500 | $16K | 7.9% |
| 19 | $10.40 | 1,100 | $11K | 5.8% |
| 20 | $10.41 | 2,100 | $22K | 11.1% |
| 21 | $10.42 | 400 | $4K | 2.1% |
| 22 | $10.43 | 200 | $2K | 1.1% |
| 23 | $10.44 | 1,100 | $11K | 5.8% |
| 24 | $10.45 | 400 | $4K | 2.1% |
| 25 | $10.46 | 100 | $1K | 0.5% |
| 26 | $10.47 | 100 | $1K | 0.5% |
| 27 | $10.48 | 200 | $2K | 1.1% |
| 28 | $10.49 | 100 | $1K | 0.5% |
| 29 | $10.50 | 400 | $4K | 2.1% |
| Total | $10.35 avg | 19,100 | $198K | 100% |
| Filing → |
| ERAS | BUY | 2023-06-08 | $275K | — | Filing → |
| ERAS | BUY | 2023-03-28 | $284K | — | Filing → |
| ERAS | BUY | 2023-01-10 | $232K | — | Filing → |